Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5282420
Max Phase: Preclinical
Molecular Formula: C21H30N6O15
Molecular Weight: 606.50
Associated Items:
ID: ALA5282420
Max Phase: Preclinical
Molecular Formula: C21H30N6O15
Molecular Weight: 606.50
Associated Items:
Canonical SMILES: NC(=O)OC[C@H](O)[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)NC(CCC(=O)O)C(=O)O)[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@H](O)[C@@H]1O
Standard InChI: InChI=1S/C21H30N6O15/c22-10(12(32)7(28)5-41-20(23)39)16(35)26-11(17(36)24-6(19(37)38)1-2-9(30)31)15-13(33)14(34)18(42-15)27-4-3-8(29)25-21(27)40/h3-4,6-7,10-15,18,28,32-34H,1-2,5,22H2,(H2,23,39)(H,24,36)(H,26,35)(H,30,31)(H,37,38)(H,25,29,40)/t6?,7-,10-,11-,12+,13-,14+,15+,18+/m0/s1
Standard InChI Key: PYCZQFQKBPZPFS-DMBGBWTBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 606.50 | Molecular Weight (Monoisotopic): 606.1769 | AlogP: -6.78 | #Rotatable Bonds: 14 |
Polar Surface Area: 356.15 | Molecular Species: ACID | HBA: 15 | HBD: 11 |
#RO5 Violations: 3 | HBA (Lipinski): 21 | HBD (Lipinski): 13 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.16 | CX Basic pKa: 7.23 | CX LogP: -8.97 | CX LogD: -12.43 |
Aromatic Rings: 1 | Heavy Atoms: 42 | QED Weighted: 0.09 | Np Likeness Score: 1.05 |
1. Serpi M, Ferrari V, Pertusati F.. (2016) Nucleoside Derived Antibiotics to Fight Microbial Drug Resistance: New Utilities for an Established Class of Drugs?, 59 (23): [PMID:27607900] [10.1021/acs.jmedchem.6b00325] |
Source(1):